Mast cell activation syndromes in clinical practice: diagnostic challenges, phenotypes, and real-life management. (PubMed, Postepy Dermatol Alergol) - Oct 18, 2026 - "Omalizumab may serve as an effective adjunct therapy in patients with persistent symptoms. A phenotype-based approach is warranted."
Journal • Allergy • Cardiovascular • Immunology
|
|
Simge Erdem; Zeynep Yegin Katran
|